Uptake of 18F-Fluciclovine in Paget Disease

Since its recent approval by the United States Food and Drug Administration, fluciclovine PET-CT has gained widespread use for imaging of recurrent prostate cancer patients. As an amino acid-based radiotracer transported by LAT-1 and ASCT-2 transporters, fluciclovine exploits the up-regulation of am...

Full description

Saved in:
Bibliographic Details
Published inClinical nuclear medicine
Main Authors Akin-Akintayo, Oladunni O, Bonta, Dacian, Barron, Bruce
Format Journal Article
LanguageEnglish
Published United States 01.11.2019
Online AccessGet more information

Cover

More Information
Summary:Since its recent approval by the United States Food and Drug Administration, fluciclovine PET-CT has gained widespread use for imaging of recurrent prostate cancer patients. As an amino acid-based radiotracer transported by LAT-1 and ASCT-2 transporters, fluciclovine exploits the up-regulation of amino acid transporters in malignant cells. We present a rare case of fluciclovine uptake in Paget disease in a 58-year-old man with suspected recurrent prostate cancer and asymmetric increased left hemipelvic uptake on imaging.
ISSN:1536-0229
DOI:10.1097/RLU.0000000000002670